2022
Primary Care Associated With Follow Up Viral Load Testing in Patients Cured of Hepatitis C Infection With Direct Acting Antivirals at a Multidisciplinary Addiction Treatment Program: Insights From a Real-World Setting
Haque LY, Butner JL, Shi JM, Henry S, Deng Y, Ciarleglio MM, Madden LM, Tetrault JM. Primary Care Associated With Follow Up Viral Load Testing in Patients Cured of Hepatitis C Infection With Direct Acting Antivirals at a Multidisciplinary Addiction Treatment Program: Insights From a Real-World Setting. Journal Of Addiction Medicine 2022, 16: 333-339. PMID: 34483278, PMCID: PMC9033626, DOI: 10.1097/adm.0000000000000910.Peer-Reviewed Original ResearchConceptsHepatitis C virus infectionUrine toxicology resultsDirect acting antiviralsViral load testingSubstance use disordersAddiction treatment programsHCV reinfectionActing antiviralsToxicology resultsUse disordersDirect acting antiviral therapyTreatment programReal-world clinical settingHCV reinfection ratesActing antiviral (DAA) therapyC virus infectionHepatitis C infectionMedical service useCohort of patientsPrimary medical careSubstance use statusAddiction treatment settingsQuality improvement initiativesHCV cureC infectionHarm reduction and abstinence-based models for treatment of substance use disorders during the COVID-19 pandemic: a global perspective
Narasimha VL, Butner J, Hanafi E, Farokhnia M, Bhad R, Chalabianloo F, Kouimtsidis C, Baldacchino A, Arunogiri S. Harm reduction and abstinence-based models for treatment of substance use disorders during the COVID-19 pandemic: a global perspective. BJPsych International 2022, 19: 66-69. PMID: 36287782, PMCID: PMC9540565, DOI: 10.1192/bji.2022.1.Peer-Reviewed Original Research
2021
A Global Survey on Changes in the Supply, Price, and Use of Illicit Drugs and Alcohol, and Related Complications During the 2020 COVID-19 Pandemic
Farhoudian A, Radfar SR, Ardabili H, Rafei P, Ebrahimi M, Zonoozi A, De Jong CAJ, Vahidi M, Yunesian M, Kouimtsidis C, Arunogiri S, Hansen H, Brady KT, Consortium I, Abagiu A, Abouna F, Ahmed M, Al-ansari B, Abu Al-khair F, Almaqbali M, Ambekar A, Arya S, Asebikan V, Ayasreh M, Basu D, Benmebarek Z, Bhad R, Blaise M, Bonnet N, Brasch J, Broers B, Busse A, Butner J, Camilleri M, Campello G, Carra G, Celic I, Chalabianloo F, Chaturvedi A, de Jesús Eduardo Noyola Cherpitel J, Clark K, Cyders M, de Bernardis E, Deilamizade A, Derry J, Dhagudu N, Dolezalova P, Dom G, Dunlop A, Elhabiby M, Elkholy H, Essien N, Farah G, Ferri M, Floros G, Friedman C, Fuderanan C, Gerra G, Ghosh A, Gogia M, Grammatikopoulos I, Grandinetti P, Guirguis A, Gutnisky D, Haber P, Hassani-Abharian P, Hooshyari Z, Ibrahim I, Ieong H, Indradewi R, Iskandar S, Isra T, Jain S, James S, Javadi S, Joe K, Jokubonis D, Jovanova A, Kamal R, Kantchelov A, Kathiresan P, Katzman G, Kawale P, Kern A, Kessler F, Kim S, Kimball A, Kljucevic Z, Kurniasanti K, Lev R, Lee H, Lengvenyte A, Lev-ran S, Mabelya G, Mahi M, Maphisa J, Maremmani I, Masferrer L, Massah O, McCambridge O, McGovern G, Min A, Moghanibashi-Mansourieh A, Mora-Rios J, Mudalige I, Mukherjee D, Munira P, Myers B, N. J, Narasimha V, Ndionuka N, Nejatisafa A, Niaz K, Nizami A, Nuijens J, Orsolini L, Oum V, Oyemade A, Palavra I, Pant S, Paredes J, Peyron E, Quirós R, Qurishi R, Rafiq N, Rao R, Ratta-apha W, Raymond K, Reimer J, Renaldo E, Rezapour T, Robertson J, Roncero C, Roub F, Rubenstein E, Rupp C, Saenz E, Salehi M, Samartzis L, Sarubbo L, Segrec N, Shah B, Shen H, Shirasaka T, Shoptaw S, Sintango F, Sosa V, Subata E, Sztycberg N, Taghizadeh F, Teck J, Tjagvad C, Torrens M, Twala J, Vadivel R, Volpicelli J, Weijs J, Wintoniw S, Wittayanookulluk A, Wojnar M, Yasir S, Yitayih Y, Zhao M, Potenza M, Baldacchino A, Ekhtiari H. A Global Survey on Changes in the Supply, Price, and Use of Illicit Drugs and Alcohol, and Related Complications During the 2020 COVID-19 Pandemic. Frontiers In Psychiatry 2021, 12: 646206. PMID: 34421664, PMCID: PMC8377291, DOI: 10.3389/fpsyt.2021.646206.Peer-Reviewed Original ResearchSubstance use disordersRelated complicationsCOVID-19 pandemicComplications of alcoholSubstance use patternsCross-sectional surveyCurrent pandemicUse of amphetaminesHypnotic usePrescription opioidsEpidemiologic studiesUse disordersMedicine NetworkComplicationsVulnerable populationsMedicine professionalsDrug supplyDrugsIllicit drugsPossible downstream effectsCOVID-19International SocietyDownstream effectsUse patternsPandemicReorganization of Substance Use Treatment and Harm Reduction Services During the COVID-19 Pandemic: A Global Survey
Radfar SR, De Jong CAJ, Farhoudian A, Ebrahimi M, Rafei P, Vahidi M, Yunesian M, Kouimtsidis C, Arunogiri S, Massah O, Deylamizadeh A, Brady KT, Busse A, Consortium I, Potenza M, Ekhtiari H, Baldacchino A, Abagiu A, Abouna F, Ahmed M, Al-ansari B, Abu Al-khair F, Almaqbali M, Ambekar A, Ardabili H, Arya S, Lasebikan V, Ayasreh M, Basu D, Benmebarek Z, Bhad R, Blaise M, Bonnet N, Brasch J, Broers B, Butner J, Camilleri M, Campello G, Carra G, Celic I, Chalabianloo F, Chaturvedi A, de Jesús Eduardo Noyola Cherpitel J, Clark K, Cyders M, de Bernardis E, Derry J, Dhagudu N, Dolezalova P, Dom G, Dunlop A, Elhabiby M, Elkholy H, Essien N, Farah G, Ferri M, Floros G, Friedman C, Fuderanan C, Gerra G, Ghosh A, Gogia M, Grammatikopoulos I, Grandinetti P, Guirguis A, Gutnisky D, Haber P, Hassani-Abharian P, Hooshyari Z, Ibrahim I, Ieong H, Indradewi R, Iskandar S, Jain S, James S, Javadi S, Joe K, Jokubonis D, Jovanova A, Kamal R, Kantchelov A, Kathiresan P, Katzman G, Kawale P, Kern A, Kessler F, Kim S, Kimball A, Kljucevic Z, Siste K, Lev R, Lee H, Lengvenyte A, Lev-ran S, Mabelya G, Mahi M, Maphisa J, Maremmani I, Masferrer L, McCambridge O, McGovern G, Min A, Moghanibashi-Mansourieh A, Mora-Rios J, Mudalige I, Mukherjee D, Munira P, Myers B, N J, Narasimha V, Ndionuka N, Nejatisafa A, Niaz K, Nizami A, Nuijens J, Orsolini L, Oum V, Oyemade A, Palavra I, Pant S, Paredes J, Peyron E, Quirós R, Qurishi R, Rafiq N, Rao R, Ratta-apha W, Raymond K, Reimer J, Renaldo E, Rezapour T, Robertson J, Roncero C, Roub F, Rubenstein E, Rupp C, Saenz E, Salehi M, Samartzis L, Sarubbo L, Segrec N, Shah B, Shen H, Shirasaka T, Shoptaw S, Sintango F, Sosa V, Subata E, Sztycberg N, Taghizadeh F, Teck J, Tjagvad C, Torrens M, Twala J, Vadivel R, Volpicelli J, Weijs J, Wintoniw S, Wittayanookulluk A, Wojnar M, Yasir S, Yitayih Y, Zhao M, Zonoozi A. Reorganization of Substance Use Treatment and Harm Reduction Services During the COVID-19 Pandemic: A Global Survey. Frontiers In Psychiatry 2021, 12: 639393. PMID: 34025471, PMCID: PMC8135096, DOI: 10.3389/fpsyt.2021.639393.Peer-Reviewed Original ResearchSubstance use disordersHarm reduction servicesSUD treatmentHealth responseReduction servicesAdequate medication supplyCoronavirus disease 2019 (COVID-19) pandemicHarm reduction programsDisease 2019 pandemicCOVID-19 pandemicOverdose prevention interventionsSubstance use treatmentEvidence-based interventionsVulnerable groupsSyringe programsTreatment modalitiesPrevention interventionsCondom distributionPsychiatric careMedication supplyUse disordersBuprenorphine supplyOutreach servicesUse treatmentMedicine professionals